Tuesday 21 May 2024
  • Triesteexpresso

Keurig Dr Pepper announces pricing of secondary offering of common stock

Must read

  • Dalla Corte
TME - Cialdy Evo

BURLINGTON, Mass. and PLANO, Texas, U.S. — Keurig Dr Pepper announced yesterday the pricing of its previously-announced registered public secondary offering of 40.0 million shares, or approximately 2.8%, of the Company’s outstanding common stock, at a price to the public of $27.25 per share. All of the shares have been offered by Maple Holdings B.V. (“Maple”).

Maple is a holding company majority-owned by JAB Holdings B.V. (“JAB”). JAB has directly purchased approximately 7.4 million shares of the Company’s common stock in this offering at a price equal to the price paid for the common stock by the underwriter. The net impact of the offering is expected to increase KDP’s float by approximately 2.3%.

La Cimbali

Upon completion of the offering, Maple and JAB will collectively own approximately 62.8% of the Company’s outstanding common stock. Maple may distribute the proceeds of the offering to its members or otherwise redeem interests of its members from time to time, including JAB. Maple and JAB collectively intend to remain a controlling shareholder in KDP.

Goldman Sachs & Co. LLC is acting as underwriter for the Keurig Dr Pepper’s offering.


The offering will be made only by means of an effective registration statement and a prospectus. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the proposed offering may be obtained from: Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing Prospectus-ny@ny.email.gs.com. Copies of the preliminary prospectus supplement and the related prospectus may also be obtained free of charge from the website of the U.S. Securities and Exchange Commission (the “SEC”) at http://www.sec.gov.

The Company has previously filed with the SEC a registration statement (including a prospectus) on Form S-­3 (File No. 333-233477) as well as a prospectus supplement, each dated August 27, 2019, for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


Latest article

  • Franke Mytico